SYMPOSIA ABSTRACTS
Symposia Session XXXVI
S-36
NEW HORIZONS IN IN THE MULTIPLE SCLEROSIS
TREATMENT
| S-36/1 | A new therapeutic target: sphingosine-1P receptors M. Di Luca (Milano) |
| S-36/2 | Fingolimod: evidences from clinical trials A. Uccelli (Genova) |